Child's Nervous System

, 27:1709

Hydrocephalus in neurocysticercosis

  • Hamilton Matushita
  • Fernando Campos Gomes Pinto
  • Daniel Dante Cardeal
  • Manoel Jacobsen Teixeira
Special Annual Issue



Cysticercosis (CC) is the most important of the parasitic diseases of the central nervous system due to its high incidence in the world. CC is the infection with the larval cysts of Taenia solium. It is the most common helminthic infection of the nervous system and is endemic in most underdeveloped countries as well as in industrialized nations. It is estimated that approximately 50,000 people die every year from neurocysticercosis (NCC) worldwide.


Humans with CC are incidental intermediate hosts, which replace the pig in the life cycle of the T. solium. Children are more frequently affected by parenchyma infestation of cysticercus, of which the main clinical manifestation is epilepsy. Hydrocephalus is more common in adults and is caused by cerebrospinal fluid blockage by ventricular cysts and inflammatory reactions (ependimitis/arachnoiditis). Treatment should be individualized based on clinical presentation, degree of infestation, location and viability of cysticercus, and host response. Hydrocephalus can be controlled only by removal of obstructive intraventricular cysts or associated with either ventriculoperitoneal shunt or endoscopic third ventriculostomy. The degree of infestation and complications related to the shunt represents the most important prognostic factors in the outcome of NCC.


Neurocysticercosis Hydrocephalus Infection Arachnoiditis Ependimitis Ventriculostomy Ventriculoperitoneal shunt 


  1. 1.
    Agapejev S (2003) Clinical and epidemiological aspects of neurocysticercosis in Brazil: a critical approach. Arq Neuropsiquiatr 61(3B):822–828PubMedCrossRefGoogle Scholar
  2. 2.
    Agapejev S, Da Silva MD, Ueda AK (1996) Severe forms of neurocysticercosis: treatment with albendazole. Arq Neuropsiquiatr 54(1):82–93PubMedCrossRefGoogle Scholar
  3. 3.
    Alcala M, Hernandez-Aguilar J, Davila G, Bernal RM (2001) . Neurocysticercosis in children: A study of 100 cases. In Fukuyama Y, Kamoshita S, Otsuka C, Suzuki Y, eds. modern Perspectives of Child Neurology. Published by Japanese Society of Child Neurology p 73-93Google Scholar
  4. 4.
    Alsina GA, Johnson JP, McBride DQ, Rhoten PR, Mehringer CM, Stokes JK (2002) Spinal neurocysticercosis. Neurosurg Focus 12(6):e8PubMedCrossRefGoogle Scholar
  5. 5.
    Amaral L, Maschietto M, Maschietto R, Cury R, Ferreira NF, Mendonca R, Lima SS (2003) Unusual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. Arq Neuropsiquiatr 61(3A):533–541PubMedCrossRefGoogle Scholar
  6. 6.
    Apuzzo ML, Dobkin WR, Zee CS, Chan JC, Giannotta SL, Weiss MH (1984) Surgical considerations in treatment of intraventricular cysticercosis. An analysis of 45 cases. J Neurosurg 60(2):400–407. doi:10.3171/jns.1984.60.2.0400 PubMedCrossRefGoogle Scholar
  7. 7.
    Bandres JC, White AC Jr, Samo T, Murphy EC, Harris RL (1992) Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis 15(5):799–811PubMedCrossRefGoogle Scholar
  8. 8.
    Bergsneider M, Holly LT, Lee JH, King WA, Frazee JG (2000) Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 92(1):14–23. doi:10.3171/jns.2000.92.1.0014 PubMedCrossRefGoogle Scholar
  9. 9.
    Braga F, Rocha AJ, Gomes HR, Filho GH, Silva CJ, Fonseca RB (2004) Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis. AJNR Am J Neuroradiol 25(2):295–297PubMedGoogle Scholar
  10. 10.
    Canelas HM (1962) Neurocysticercosis: incidence, diagnosis and clinical forms. Arq Neuropsiquiatr 20:1–16PubMedGoogle Scholar
  11. 11.
    Cantu C, Barinagarrementeria F (1996) Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 53(3):233–239PubMedGoogle Scholar
  12. 12.
    Cardenas YCJ (1962) Cysticercosis of central nervous system: II. Pathologic and radiologic findings. J Neurosurg 19:635CrossRefGoogle Scholar
  13. 13.
    Carpio A (2002) Neurocysticercosis: an update. Lancet Infect Dis 2(12):751–762PubMedCrossRefGoogle Scholar
  14. 14.
    Carpio A, Escobar A, Hauser WA (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39(10):1025–1040PubMedCrossRefGoogle Scholar
  15. 15.
    Chimelli L, Lovalho AF, Takayanagui OM (1998) Neurocysticercosis: contribution of autopsies in the consolidation of mandatory notification in Ribeirao Preto—SP, Brazil. Arq Neuropsiquiatr 56(3B):577–584PubMedCrossRefGoogle Scholar
  16. 16.
    Colli BO, Carlotti CG Jr, Assirati JA Jr, Machado HR, Valenca M, Amato MC (2002) Surgical treatment of cerebral cysticercosis: long-term results and prognostic factors. Neurosurg Focus 12(6):e3PubMedGoogle Scholar
  17. 17.
    Colli BO, Martelli N, Assirati JA Jr, Machado HR, de Vergueiro FS (1986) Results of surgical treatment of neurocysticercosis in 69 cases. J Neurosurg 65(3):309–315. doi:10.3171/jns.1986.65.3.0309 PubMedCrossRefGoogle Scholar
  18. 18.
    Couldwell WT, Zee CS, Apuzzo ML (1991) Definition of the role of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurgery 28(2):231–237PubMedCrossRefGoogle Scholar
  19. 19.
    Cuetter AC, Andrews RJ (2002) Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature. Neurosurg Focus 12(6):e5PubMedCrossRefGoogle Scholar
  20. 20.
    Cuetter AC, Garcia-Bobadilla J, Guerra LG, Martinez FM, Kaim B (1997) Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 24(2):157–164PubMedCrossRefGoogle Scholar
  21. 21.
    Del Brutto OH (1994) Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44(9):1706–1709PubMedGoogle Scholar
  22. 22.
    Del Brutto OH, Campos X, Sanchez J, Mosquera A (1999) Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 52(5):1079–1081PubMedGoogle Scholar
  23. 23.
    Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, Schantz PM, Evans CA, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, Garcia HH (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57(2):177–183PubMedGoogle Scholar
  24. 24.
    DeGiorgio CM, Houston I, Oviedo S, Sorvillo F (2001) Deaths associated with cysticercosis. Report of three cases and review of the literature. Neurosurg Focus 12(6):e2.Google Scholar
  25. 25.
    do Amaral LL, Ferreira RM, da Rocha AJ, Ferreira NP (2005) Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 16(2):127–144PubMedCrossRefGoogle Scholar
  26. 26.
    Escobar A (1983) the pathology of neuroxysticercosis. In: Palacios EE, Rodrigues-Carbajal J, Taveras JM (eds) Cysticercosi of central nervous system. Thomas, Springfield, p 23Google Scholar
  27. 27.
    Estanol B, Kleriga E, Loyo M, Mateos H, Lombardo L, Gordon F, Saguchi AF (1983) Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy. Neurosurgery 13(2):119–123PubMedCrossRefGoogle Scholar
  28. 28.
    Flisser A (1988) Neurocysticercosis in Mexico. Parasitol Today 4(5):131–137PubMedCrossRefGoogle Scholar
  29. 29.
    Flisser A, Rodriguez-Canul R, Willingham AL 3rd (2006) Control of the taeniosis/cysticercosis complex: future developments. Vet Parasitol 139(4):283–292. doi:10.1016/j.vetpar.2006.04.019 PubMedCrossRefGoogle Scholar
  30. 30.
    Flisser A, Sarti E, Lightowlers M, Schantz P (2003) Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop 87(1):43–51PubMedGoogle Scholar
  31. 31.
    Garcia HH (2008) Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel? Expert Rev Anti Infect Ther 6(3):295–298. doi:10.1586/14787210.6.3.295 PubMedCrossRefGoogle Scholar
  32. 32.
    Garcia HH, Del Brutto OH (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4(10):653–661. doi:10.1016/S1474-4422(05)70194-0 PubMedCrossRefGoogle Scholar
  33. 33.
    Garcia HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, Rajshekhar V, Tsang VC, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez AE, Gilman RH, Del Brutto OH (2002) Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15(4):747–756PubMedCrossRefGoogle Scholar
  34. 34.
    Garcia HH, Gilman RH, Horton J, Martinez M, Herrera G, Altamirano J, Cuba JM, Rios-Saavedra N, Verastegui M, Boero J, Gonzalez AE (1997) Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology 48(5):1421–1427PubMedGoogle Scholar
  35. 35.
    Garcia HH, Gonzalez AE, Evans CA, Gilman RH (2003) Taenia solium cysticercosis. Lancet 362(9383):547–556. doi:10.1016/S0140-6736(03)14117-7 PubMedCrossRefGoogle Scholar
  36. 36.
    Garcia HH, Gonzalez AE, Gilman RH (2003) Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis 16(5):411–419. doi:10.1097/01.qco.0000092812.64370.f7 PubMedCrossRefGoogle Scholar
  37. 37.
    Garg RK, Potluri N, Kar AM, Singh MK, Shukla R, Agrawal A, Verma R (2006) Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 53(1):65–69. doi:10.1016/j.jinf.2005.09.002 PubMedCrossRefGoogle Scholar
  38. 38.
    Gekeler F, Eichenlaub S, Mendoza EG, Sotelo J, Hoelscher M, Loscher T (2002) Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis. Eur J Clin Microbiol Infect Dis 21(3):227–229. doi:10.1007/s10096-002-0695-3 PubMedCrossRefGoogle Scholar
  39. 39.
    Gravori T, Steineke T, Bergsneider M (2002) Endoscopic removal of cisternal neurocysticercal cysts. Technical note. Neurosurg Focus 12(6):e7PubMedCrossRefGoogle Scholar
  40. 40.
    Husain M, Rastogi M, Jha DK, Husain N, Gupta RK (2007) Endoscopic transaqueductal removal of fourth ventricular neurocysticercosis with an angiographic catheter. Neurosurgery 60(4 Suppl 2):249–253. doi:10.1227/01.NEU.0000255382.72593.81, discussion 254PubMedGoogle Scholar
  41. 41.
    Itabashi HH (1983) Pathology of CNS cysticercosis. Bull Clin Neurosci 48:6–17PubMedGoogle Scholar
  42. 42.
    Jayakumar PN, Chandrashekar HS, Srikanth SG, Guruprasad AS, Devi BI, Shankar SK (2004) MRI and in vivo proton MR spectroscopy in a racemose cysticercal cyst of the brain. Neuroradiology 46(1):72–74. doi:10.1007/s00234-003-1108-8 PubMedCrossRefGoogle Scholar
  43. 43.
    Kalra V, Suri M, Jailkhani BL (1994) A profile of childhood neurocysticercosis. Indian J Pediatr 61(1):33–42PubMedCrossRefGoogle Scholar
  44. 44.
    Kelley R, Duong DH, Locke GE (2002) Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 50(4):757–761, discussion 761–752PubMedCrossRefGoogle Scholar
  45. 45.
    Ko DY, Chang GY (1998) Albendazole therapy for neurocysticercosis. Neurology 50(3):834–835PubMedGoogle Scholar
  46. 46.
    Lefevre AB (1966) Clinical study of intracranial tumors in children. Considerations on 127 cases. Rev Hosp Clin Fac Med Sao Paulo 21(1):1–31PubMedGoogle Scholar
  47. 47.
    Lightowlers MW (2010) Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int J Parasitol 40(10):1183–1192. doi:10.1016/j.ijpara.2010.05.001 PubMedCrossRefGoogle Scholar
  48. 48.
    Lobato RD, Lamas E, Portillo JM, Roger R, Esparza J, Rivas JJ, Munoz MJ (1981) Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg 55(5):786–793. doi:10.3171/jns.1981.55.5.0786 PubMedCrossRefGoogle Scholar
  49. 49.
    Lopez-Hernandez A (1983) Clinical manifestations and sequential computed tomography scans of cerebral cysticercosis in childhood. Brain Dev 5(3):269–277PubMedGoogle Scholar
  50. 50.
    Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR, Leite CC (2007) The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden. AJNR Am J Neuroradiol 28(8):1501–1504. doi:10.3174/ajnr.A0623 PubMedCrossRefGoogle Scholar
  51. 51.
    Madrazo I, Garcia-Renteria JA, Sandoval M, Lopez Vega FJ (1983) Intraventricular cysticercosis. Neurosurgery 12(2):148–152PubMedCrossRefGoogle Scholar
  52. 52.
    Mendes EC, da Silva SS, Fonseca EA, de Souza HR, de Carvalho RW (2005) Human neurocysticercosis in Baixada Fluminense, Rio de Janeiro State, Brazil. Arq Neuropsiquiatr 63(4):1058–1062. doi:/S0004-282X2005000600027 PubMedCrossRefGoogle Scholar
  53. 53.
    MLG M (1990) Neurocisticercose na infância: aspectos de correlações clinicas e tomográficas (tese de doutorado). Faculdade de Medicina da Universidade de São Paulo, São PauloGoogle Scholar
  54. 54.
    MLG M (1996) Neurocisticercose na infancia. Aspectos terapeuticos. Machado LR, Livramento JA, Spina FN, Nobrega JPS (eds) Neuroinfecção 96 São Paulo: Clinica Neurologica HC/FMUSP:219Google Scholar
  55. 55.
    Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM (2000) Clinical aspects of neurocysticercosis in children. Pediatr Neurol 22(4):287–291PubMedCrossRefGoogle Scholar
  56. 56.
    Neal JH (1995) An endoscopic approach to cysticercosis cysts of the posterior third ventricle. Neurosurgery 36(5):1040–1043PubMedCrossRefGoogle Scholar
  57. 57.
    Nicoletti A, Bartoloni A, Sofia V, Bartalesi F, Chavez JR, Osinaga R, Paradisi F, Dumas JL, Tsang VC, Reggio A, Hall AJ (2005) Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia 46(7):1127–1132. doi:10.1111/j.1528-1167.2005.67804.x PubMedCrossRefGoogle Scholar
  58. 58.
    NJ C (1995) Epidemiological status of the taeniasis/cysticercosis in the State of Paraná (south region of Brazil) and the control strategies. Taeniasis/cysticercosis complex: future trends towards its control. PAHO/WHOGoogle Scholar
  59. 59.
    Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, Pinner RW (2002) Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8(6):608–613PubMedGoogle Scholar
  60. 60.
    Pfuetzenreiter MR, de Avila-Pires FD (1999) Clinical manifestations in patients with computerized tomography diagnosis of neurocysticercosis. Arq Neuropsiquiatr 57(3A):653–658PubMedCrossRefGoogle Scholar
  61. 61.
    Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A (2004) Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients. Trans R Soc Trop Med Hyg 98(8):478–484. doi:10.1016/j.trstmh.2003.12.006 PubMedCrossRefGoogle Scholar
  62. 62.
    Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I (2001) Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 345(12):879–885. doi:10.1056/NEJMoa010212 PubMedCrossRefGoogle Scholar
  63. 63.
    Proano JV, Madrazo I, Garcia L, Garcia-Torres E, Correa D (1997) Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 87(1):29–33. doi:10.3171/jns.1997.87.1.0029 PubMedCrossRefGoogle Scholar
  64. 64.
    Proano JV, Torres-Corzo J, Rodriguez-Della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L (2009) Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst 25(11):1467–1475. doi:10.1007/s00381-009-0933-4 PubMedCrossRefGoogle Scholar
  65. 65.
    Raffin LS, Bacheschi LA, Machado LR, Nobrega JP, Coelho C, Leite CC (2001) Diffusion-weighted MR imaging of cystic lesions of neurocysticercosis: a preliminary study. Arq Neuropsiquiatr 59(4):839–842PubMedCrossRefGoogle Scholar
  66. 66.
    Rajshekhar V, Jeyaseelan L (2004) Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 62(12):2236–2240PubMedGoogle Scholar
  67. 67.
    Rangel-Castilla L, Serpa JA, Gopinath SP, Graviss EA, Diaz-Marchan P, White AC Jr (2009) Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg 80(3):373–378PubMedGoogle Scholar
  68. 68.
    Rodriguez-Carbajal J, Boleaga-Duran B, Dorfsman J (1987) The role of computed tomography (CT) in the diagnosis of neurocysticercosis. Childs Nerv Syst 3(4):199–202PubMedCrossRefGoogle Scholar
  69. 69.
    Rueda-Franco F (1987) Surgical considerations in neurocysticercosis. Childs Nerv Syst 3(4):212PubMedCrossRefGoogle Scholar
  70. 70.
    Salgado P, Rojas R, Sotelo J (1997) Cysticercosis. Clinical classification based on imaging studies. Arch Intern Med 157(17):1991–1997PubMedCrossRefGoogle Scholar
  71. 71.
    Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, Roberts J, Flisser A (1994) Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 18(6):879–885PubMedCrossRefGoogle Scholar
  72. 72.
    Schantz PM Wilkins PP, Tsang VCW (1998) Immigrants, imaging, and immunoblots: the emergence of neurocysticercosis as a major public health problem. In: Scheld WM, Craig WA, Hughes JM (eds) Emerging infections 2. ASM, Washington, pp. 213–242Google Scholar
  73. 73.
    Schenone HVF, Rojas A, Ramirez R (1982) Epidemiology of humans cysticercosis in Latin America. In: Flisser A, Willms K, Laclette JP, Larralde C (eds) Cysticercosis: present state of knowledge and perspectives. Academic, New York, pp 25–38Google Scholar
  74. 74.
    Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R (1994) Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) 73(1):37–52Google Scholar
  75. 75.
    Sorvillo FJ, DeGiorgio C, Waterman SH (2007) Deaths from cysticercosis, United States. Emerg Infect Dis 13(2):230–235PubMedCrossRefGoogle Scholar
  76. 76.
    Sotelo J (1997) Treatment of brain cysticercosis. Surg Neurol 48(2):110–112PubMedCrossRefGoogle Scholar
  77. 77.
    Sotelo J, Del Brutto OH (2000) Brain cysticercosis. Arch Med Res 31(1):3–14PubMedCrossRefGoogle Scholar
  78. 78.
    Sotelo J, Marin C (1987) Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg 66(5):686–689. doi:10.3171/jns.1987.66.5.0686 PubMedCrossRefGoogle Scholar
  79. 79.
    Sotelo J, Torres B, Rubio-Donnadieu F, Escobedo F, Rodriguez-Carbajal J (1985) Praziquantel in the treatment of neurocysticercosis: long-term follow-up. Neurology 35(5):752–755PubMedGoogle Scholar
  80. 80.
    Stepien L (1962) Cerebral cysticercosis in Poland. Clinical symptoms and operative results in 132 cases. J Neurosurg 19:505–513. doi:10.3171/jns.1962.19.6.0505 PubMedCrossRefGoogle Scholar
  81. 81.
    Suastegui Roman RA, Soto-Hernandez JL, Sotelo J (1996) Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg 84(4):629–633. doi:10.3171/jns.1996.84.4.0629 PubMedCrossRefGoogle Scholar
  82. 82.
    Suri A, Goel RK, Ahmad FU, Vellimana AK, Sharma BS, Mahapatra AK (2008) Endoscopic excision of intraventricular neurocysticercosis in children: a series of six cases and review. Childs Nerv Syst 24(2):281–285. doi:10.1007/s00381-007-0462-y PubMedCrossRefGoogle Scholar
  83. 83.
    Suri A, Goel RK, Ahmad FU, Vellimana AK, Sharma BS, Mahapatra AK (2008) Transventricular, transaqueductal scope-in-scope endoscopic excision of fourth ventricular neurocysticercosis: a series of 13 cases and a review. J Neurosurg Pediatr 1(1):35–39. doi:10.3171/PED-08/01/035 PubMedCrossRefGoogle Scholar
  84. 84.
    Takayanagui OM (1990) Neurocysticercosis. I. Clinical and laboratory course of 151 cases. Arq Neuropsiquiatr 48(1):1–10PubMedGoogle Scholar
  85. 85.
    Takayanagui OM, Castro e Silva AA, Santiago RC, Odashima NS, Terra VC, Takayanagui AM (1996) Compulsory notification of cysticercosis in Ribeirao Preto—SP, Brazil. Arq Neuropsiquiatr 54(4):557–564PubMedCrossRefGoogle Scholar
  86. 86.
    Takayanagui OM, Jardim E (1983) Clinical aspects of neurocysticercosis: analysis of 500 cases. Arq Neuropsiquiatr 41(1):50–63PubMedGoogle Scholar
  87. 87.
    Thussu A, Sehgal S, Sharma M, Lal V, Sawhney IM, Prabhakar S (1997) Comparison of cellular responses in single- and multiple-lesion neurocysticercosis. Ann Trop Med Parasitol 91(6):627–632PubMedCrossRefGoogle Scholar
  88. 88.
    Torres-Corzo J, Rodriguez-della Vecchia R, Rangel-Castilla L (2006) Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J Neurosurg 104(5):746–748. doi:10.3171/jns.2006.104.5.746 PubMedCrossRefGoogle Scholar
  89. 89.
    Tsang VC, Brand JA, Boyer AE (1989) An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159(1):50–59PubMedCrossRefGoogle Scholar
  90. 90.
    Wallin MT, Kurtzke JF (2004) Neurocysticercosis in the United States: review of an important emerging infection. Neurology 63(9):1559–1564PubMedGoogle Scholar
  91. 91.
    White AC Jr (1997) Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 24(2):101–113, quiz 114–105PubMedCrossRefGoogle Scholar
  92. 92.
    White AC Jr (2000) Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 51:187–206. doi:10.1146/ PubMedCrossRefGoogle Scholar
  93. 93.
    Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo ML (1993) MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 17(6):932–939PubMedCrossRefGoogle Scholar
  94. 94.
    Zymberg ST, Paiva Neto MA, Gorgulho AA, Cavalheiro S (2003) Endoscopic approach to fourth ventricle cysticercosis. Arq Neuropsiquiatr 61(2A):204–207PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Hamilton Matushita
    • 1
  • Fernando Campos Gomes Pinto
    • 1
  • Daniel Dante Cardeal
    • 1
  • Manoel Jacobsen Teixeira
    • 1
  1. 1.Department of Neurosurgery/Pediatric Neurosurgery, Clinic HospitalSão Paulo University Medical SchoolSão PauloBrazil

Personalised recommendations